Iovance Biotherapeutics Inc
Iovance Biotherapeutics Inc logo
IOVA

Iovance Biotherapeutics Inc (IOVA)

$11.123.05%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$10.985
Day's Range
$11.575
$6.18
52-Week Range
$27.96
1 month return52.32%
3 month return32.29%
1 year return54.66%
5 year return96.07%

Company Information

Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient's own immune cells to attack cancer. TIL cells are extracted from a patient's own tumor tissue, expanded through a proprietary process, and infused back into the patient. Upon infusion, TIL reach tumor tissue, where they attack cancer cells. The company has completed dosing in pivotal programs in patients with metastatic melanoma and cervical cancer. In addition, the company's TIL therapy is being investigated in a registration-supporting study for the treatment of patients with locally advanced, recurrent or metastatic non-small cell lung cancer. Clinical studies are also underway to evaluate TIL in earlier stage cancers in combination with currently approved treatments, and to investigate Iovance peripheral blood lymphocyte (PBL) T cell therapy for blood cancers.
OrganizationIovance Biotherapeutics Inc
CEOMaria Fardis
IndustryHealth Technology

Analyst Recommendation

based on 20 analysts ratings

Buy
85%
Buy
15%
Hold
0%
Sell

Based on 20 Wall street analysts offering stock ratings for Iovance Biotherapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 177.94%

Current

$11.47

Target

$31.88

Recommendation Trend

Based on 20 analyst

Current1M Ago3M Ago
Buy
17
17
16
Hold
3
3
4
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
2.4B
Book Value
3.96
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-2.23
PEG Ratio
0.0
Wall Street Target Price
35.08

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
0.0
Price/Book (mrq)
4.11
Enterprise Value
2.1B
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.0

Technicals

Beta
0.83
50 Day MA
15.81
200 Day MA
19.92

Institutional Holdings

Vanguard Group Inc

7.85%

Perceptive Advisors LLC

7.76%

Wellington Management Company LLP

7.18%

venBio Select Advisor LLC

5.81%

BlackRock Inc

4.71%

State Street Corporation

4.36%

Discover more

Frequently Asked Questions

What is Iovance Biotherapeutics Inc share price today?

Can Indians buy Iovance Biotherapeutics Inc shares?

How can I buy Iovance Biotherapeutics Inc shares from India?

Can Fractional shares of Iovance Biotherapeutics Inc be purchased?

What are the documents required to start investing in Iovance Biotherapeutics Inc stocks?

What are today’s High and Low prices of Iovance Biotherapeutics Inc?

What are today’s traded volumes of Iovance Biotherapeutics Inc?

What is today’s market capitalisation of Iovance Biotherapeutics Inc?

What is the 52 Week High and Low Range of Iovance Biotherapeutics Inc?

How much percentage Iovance Biotherapeutics Inc is down from its 52 Week High?

How much percentage Iovance Biotherapeutics Inc is up from its 52 Week low?

What are the historical returns of Iovance Biotherapeutics Inc?

Who is the Chief Executive Officer (CEO) of Iovance Biotherapeutics Inc?